Optimizing Donor Cellular Dissociation and Subretinal Injection Parameters for Stem Cell‐Based Treatments

Subretinal delivery of stem cell‐derived retinal cells as a strategy to treat retinal degenerative blindness holds great promise. Currently, two clinical trials are underway in which human fetal retinal progenitor cells (RPCs) are being delivered to patients by intravitreal or subretinal injection t...

Descripción completa

Detalles Bibliográficos
Autores principales: Scruggs, Brittni A., Jiao, Chunhua, Cranston, Cathryn M., Kaalberg, Emily, Wang, Kai, Russell, Stephen R., Wiley, Luke A., Mullins, Robert F., Stone, Edwin M., Tucker, Budd A., Sohn, Elliott H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Standards, Protocols, Policies, and Regulations for Cell‐Based Therapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646699/
https://www.ncbi.nlm.nih.gov/pubmed/31004408
http://dx.doi.org/10.1002/sctm.18-0210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646699/
https://www.ncbi.nlm.nih.gov/pubmed/31004408
http://dx.doi.org/10.1002/sctm.18-0210

Ejemplares similares